Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
Clinical trial NCT00095160 · COMPLETED
Trial details
- NCT number
- NCT00095160
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2006-01-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.